Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Paul, Worth"'
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 90:e39.2-e39
Smell loss (anosmia) is a common finding in people with PD, although it is also quite common in older age (Ross 2008). Population studies assessing the prodromal phase of PD have therefore included individuals with smell loss. However, the differenti
Publikováno v:
British Journal of Neuroscience Nursing. 9:292-300
There is increasing recognition that integrated services provide improved quality and cost-effective care ( Ham, 2011 ; Ham and Curry, 2011 ; Goodwin et al, 2012 ). This article outlines the steps taken to create an integrated care pathway for people
Autor:
Edward Needham, Paul Worth
Publikováno v:
Prescriber. 23:21-31
Parkinson's is a progressive debilitating disease and pharmacological management is complex. Our Drug review describes the available drug options for the treatment of parkinsonian motor symptoms, followed by an analysis of the prescription data and s
Autor:
Paul Worth
Publikováno v:
Practical neurology. 15(6)
Two questions central to the management of early Parkinson's disease are when to treat and with what to treat. When to treat remains controversial, with the available medications for Parkinson's disease showing no definite evidence of any disease-mod
Autor:
Henry, Houlden, Janel, Johnson, Christopher, Gardner-Thorpe, Tammaryn, Lashley, Dena, Hernandez, Paul, Worth, Andrew B, Singleton, David A, Hilton, Janice, Holton, Tamas, Revesz, Mary B, Davis, Paola, Giunti, Paolo, Giunti, Nicholas W, Wood
Publikováno v:
Nature genetics. 39(12)
The microtubule-associated protein tau ( encoded by MAPT) and several tau kinases have been implicated in neurodegeneration, but only MAPT has a proven role in disease. We identified mutations in the gene encoding tau tubulin kinase 2 ( TTBK2) as the
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 86:e4.184-e4
Ataxia telangiectasia-like disorder (ATLD) is a very rare autosomal recessive disease with only 25 patients recognised worldwide. ATLD is likened to Ataxia telangiectasia (A-T) due to an overlap of clinical presentations and cellular characteristics.
Autor:
Paul Worth, Negin Damali Amiri
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 85:e4.149-e4
Aim For patients with Parkinson9s Disease (PD), adherence to the patient9s usual PD medication schedule is paramount for symptom control and prevention of complications. The ‘Get It On Time’ campaign, initiated by Parkinson9s UK, aims to raise aw
Autor:
Henry Houlden, Janel Johnson, Christopher Gardner-Thorpe, Tammaryn Lashley, Dena Hernandez, Paul Worth, Andrew B Singleton, David A Hilton, Janice Holton, Tamas Revesz, Mary B Davis, Paolo Giunti, Nicholas W Wood
Publikováno v:
Nature Genetics. 40:255-255